254 related articles for article (PubMed ID: 25609361)
1. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
[TBL] [Abstract][Full Text] [Related]
2. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Ma DX; Shi NQ; Qi XR
Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
4. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-tumor activity of trichosanthin after combination with a human-derived cell-penetrating peptide, and a possible mechanism of activity.
Lu YZ; Li PF; Li YZ; Luo F; Guo C; Lin B; Cao XW; Zhao J; Wang FJ
Fitoterapia; 2016 Jul; 112():183-90. PubMed ID: 27050721
[TBL] [Abstract][Full Text] [Related]
6. Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix.
Chen Y; Li S; Zhao J; Cao X; Wang F
J Drug Target; 2022 Mar; 30(3):326-333. PubMed ID: 34708678
[TBL] [Abstract][Full Text] [Related]
7. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
8. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating peptides: breaking through to the other side.
Koren E; Torchilin VP
Trends Mol Med; 2012 Jul; 18(7):385-93. PubMed ID: 22682515
[TBL] [Abstract][Full Text] [Related]
10. Intelligent substance delivery into cells using cell-penetrating peptides.
Tashima T
Bioorg Med Chem Lett; 2017 Jan; 27(2):121-130. PubMed ID: 27956345
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
Young Kim H; Young Yum S; Jang G; Ahn DR
Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
[TBL] [Abstract][Full Text] [Related]
12. Curvature engineering: positive membrane curvature induced by epsin N-terminal peptide boosts internalization of octaarginine.
Pujals S; Miyamae H; Afonin S; Murayama T; Hirose H; Nakase I; Taniuchi K; Umeda M; Sakamoto K; Ulrich AS; Futaki S
ACS Chem Biol; 2013 Sep; 8(9):1894-9. PubMed ID: 23834464
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.
Freire JM; Veiga AS; Rego de Figueiredo I; de la Torre BG; Santos NC; Andreu D; Da Poian AT; Castanho MA
FEBS J; 2014 Jan; 281(1):191-215. PubMed ID: 24286593
[TBL] [Abstract][Full Text] [Related]
14. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.
De Coupade C; Fittipaldi A; Chagnas V; Michel M; Carlier S; Tasciotti E; Darmon A; Ravel D; Kearsey J; Giacca M; Cailler F
Biochem J; 2005 Sep; 390(Pt 2):407-18. PubMed ID: 15859953
[TBL] [Abstract][Full Text] [Related]
15. Cell penetrating peptides: a comparative transport analysis for 474 sequence motifs.
Ramaker K; Henkel M; Krause T; Röckendorf N; Frey A
Drug Deliv; 2018 Nov; 25(1):928-937. PubMed ID: 29656676
[TBL] [Abstract][Full Text] [Related]
16. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
18. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
Ye J; Shin MC; Liang Q; He H; Yang VC
J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
[TBL] [Abstract][Full Text] [Related]
19. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.
Zhang X; Jin Y; Plummer MR; Pooyan S; Gunaseelan S; Sinko PJ
Mol Pharm; 2009; 6(3):836-48. PubMed ID: 19278221
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptides transport therapeutics into cells.
Ramsey JD; Flynn NH
Pharmacol Ther; 2015 Oct; 154():78-86. PubMed ID: 26210404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
